1. Home
  2. AGEN vs SLNG Comparison

AGEN vs SLNG Comparison

Compare AGEN & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.05

Market Cap

126.2M

Sector

Health Care

ML Signal

HOLD

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$5.00

Market Cap

103.2M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
SLNG
Founded
1994
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil/Gas Transmission
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
126.2M
103.2M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
AGEN
SLNG
Price
$3.05
$5.00
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$14.50
$10.00
AVG Volume (30 Days)
613.6K
12.7K
Earning Date
03-10-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$106,829,000.00
$72,270,000.00
Revenue This Year
$5.19
$7.02
Revenue Next Year
$68.25
$7.68
P/E Ratio
N/A
$101.76
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$3.29
52 Week High
$7.34
$8.08

Technical Indicators

Market Signals
Indicator
AGEN
SLNG
Relative Strength Index (RSI) 45.17 44.48
Support Level $2.76 $5.41
Resistance Level $3.15 $5.66
Average True Range (ATR) 0.18 0.24
MACD 0.02 -0.06
Stochastic Oscillator 61.00 8.65

Price Performance

Historical Comparison
AGEN
SLNG

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

Share on Social Networks: